Johnson & Johnson agreed to pay $117 million to settle 41 states’ claims that it misrepresented the risks of vaginal-mesh products used to bolster sagging organs and treat incontinence in women. A group of state attorneys general argued after an …
Allergan Plc will stop selling some breast implants after the U.S. Food and Drug Administration said that textured implants had been associated with a rare type of blood cancer. Allergan’s textured Biocell saline-filled and silicone-filled breast implants and tissue expanders …
Johnson & Johnson agreed to pay about $1 billion to resolve most lawsuits claiming it sold defective metal-on-metal hips that ultimately had to be removed, according to people with knowledge of the matter. With the agreement, J&J has now resolved …
U.S. health regulators ordered two medical device companies to stop selling a surgical mesh used in pelvic repair surgeries, after thousands of claims by women that they were injured by the products. The Food and Drug Administration said it had …
Government medical advisers said this week it’s too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem. The Food and Drug …
U.S. health officials are telling doctors to be on the lookout for a rare cancer linked to breast implants after receiving more reports of the disease. The Food and Drug Administration sent a letter to family doctors, nurses and other …
Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay $120 million to resolve deceptive marketing claims by several U.S. states over the company’s metal-on-metal hip implants. Attorneys general of 46 U.S. states announced the settlement agreement in …
Johnson & Johnson has begun settling consumers’ claims that it sold artificial hips knowing they were defective, marking the first settlements in the seven-year-old litigation. A federal judge in Texas overseeing the cases said about 3,300 of 10,000 “have settled …
An Olympus Corp. subsidiary pleaded guilty on Monday and agreed to pay $85 million to resolve charges that it failed to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used …
Medtronic Plc said on Tuesday it would pay $50.9 million to resolve U.S. Justice Department probes into how companies it later acquired marketed medical devices, including one meant to treat a vascular defect in the brain. As part of the …
